<DOC>
	<DOC>NCT00630123</DOC>
	<brief_summary>To investigate the change in brain derived neurotrophic factor (BDNF) between pre and post treatment for patients with depression with either ECT or TMS.</brief_summary>
	<brief_title>Effect of Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation(TMS) on Brain Derived Neurotrophic Factor (BDNF) in Depressed Patients.</brief_title>
	<detailed_description />
	<criteria>MDD or bipolar disorder; current depressive episode, hamd17&gt;17 and ymrs&lt;8; recommended to receive ECT or TMS as part of clinical care; male/female; age 1865; inpatient or outpatient; comorbid dysthymic disorder, gad, or social anxiety will be included; able to give written consent and agree. current manic, hypomanic, or mixed episode, ymrs&gt;7; current schizophrenia, anorexia, bulimia, substance dependence (current within past 6 months excluding caffeine and nicotine); TMS or ECT in the last 3 months; any other primary diagnosis; uncontrolled medical illness; epilepsy or severe personality disorder at the discretion of the investigators; 3 weeks prior to first blood test, antidepressants, mood stabilizers, antipsychotics can not be added or increased; pregnant women or women of childbearing potential not willing to use appropriate contraception, nursing women; known intolerance or lack of response to treatment receiving as judged by the investigator; medical conditions that would affect serum levels of BDNF; involvement in planning and conduct of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>